SynopsisRivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of.....
SynopsisDental issues are one of the most common problems across the globe. Dental diagnostic and surgical devices are used to identify the nature or cause of a certain dental problem. The global Dental Surgical Devices market was valued at US$ 3306 million in 2.....
SynopsisThe Radiopharmaceuticals in Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and globa.....
SynopsisThe Therapy Robot market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha.....
SynopsisThe Rehabilitation Exercise Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke.....
SynopsisNeedleless connectors with positive displacement feature is designed to help reduce catheter occlusions while preventing healthcare workers from accidental needle stick injuries. The global Positive Displacement Needleless Connectors market was va.....
SynopsisMalar implant is a facial implant designed to enhance the appearance of the cheekbones for aesthetic purposes. The global Malar Implant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % durin.....
SynopsisAntihemorrhagic Agent is a substance that promotes hemostasis (stops bleeding). The global Antihemorrhagic Agent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significan.....
SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market size is expected to reach US$ 331.5 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is ma.....
SynopsisThe global Medical Molecular Imaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Medical Molecular Imaging in various end use industries. The exp.....
